Axl in ovarian cancer: A step forward for clinical breakthrough?

Marialuisa Sensi; Silvana Canevari; Antonella Tomassetti

doi:10.18632/oncotarget.13457

Axl in ovarian cancer: A step forward for clinical breakthrough?

Marialuisa Sensi, Silvana Canevari, Antonella Tomassetti

Fondazione IRCCS Istituto Nazionale dei Tumori

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	80105-80106
Number of pages	2
Journal	Oncotarget
Volume	7
Issue number	49
DOIs	https://doi.org/10.18632/oncotarget.13457
Publication status	Published - 2016

Keywords

Axl
Epithelial ovarian cancer
Prognosis
Targeted therapy
Tumor progression

ASJC Scopus subject areas

Oncology

Access to Document

10.18632/oncotarget.13457

Cite this

Sensi, M., Canevari, S., & Tomassetti, A. (2016). Axl in ovarian cancer: A step forward for clinical breakthrough? Oncotarget, 7(49), 80105-80106. https://doi.org/10.18632/oncotarget.13457

@article{37e7ae723b4046358c0d522b17c226cf,

title = "Axl in ovarian cancer: A step forward for clinical breakthrough?",

keywords = "Axl, Epithelial ovarian cancer, Prognosis, Targeted therapy, Tumor progression",

author = "Marialuisa Sensi and Silvana Canevari and Antonella Tomassetti",

year = "2016",

doi = "10.18632/oncotarget.13457",

language = "English",

volume = "7",

pages = "80105--80106",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "49",

}

TY - JOUR

T1 - Axl in ovarian cancer

T2 - A step forward for clinical breakthrough?

AU - Sensi, Marialuisa

AU - Canevari, Silvana

AU - Tomassetti, Antonella

PY - 2016

Y1 - 2016

KW - Axl

KW - Epithelial ovarian cancer

KW - Prognosis

KW - Targeted therapy

KW - Tumor progression

UR - http://www.scopus.com/inward/record.url?scp=85001085902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85001085902&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.13457

DO - 10.18632/oncotarget.13457

M3 - Editorial

AN - SCOPUS:85001085902

VL - 7

SP - 80105

EP - 80106

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 49

ER -